ELI LILLY & CO (LLY.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:LLY - US5324571083 - Common Stock
866.4 EUR
-6.3 (-0.72%)
LLY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 55 industry peers in the Pharmaceuticals industry. While LLY has a great profitability rating, there are some minor concerns on its financial health. LLY is valued quite expensively, but it does show have an excellent growth rating. These ratings would make LLY suitable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year LLY was profitable.
In the past year LLY had a positive cash flow from operations.
Each year in the past 5 years LLY has been profitable.
Each year in the past 5 years LLY had a positive operating cash flow.
1.2 Ratios
LLY has a better Return On Assets (16.02%) than 92.59% of its industry peers.
The Return On Equity of LLY (77.38%) is better than 96.30% of its industry peers.
The Return On Invested Capital of LLY (28.84%) is better than 96.30% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LLY is significantly above the industry average of 13.89%.
The 3 year average ROIC (21.71%) for LLY is below the current ROIC(28.84%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROIC | 28.84% |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
1.3 Margins
The Profit Margin of LLY (30.99%) is better than 98.15% of its industry peers.
LLY's Profit Margin has declined in the last couple of years.
LLY's Operating Margin of 44.41% is amongst the best of the industry. LLY outperforms 98.15% of its industry peers.
In the last couple of years the Operating Margin of LLY has grown nicely.
LLY has a better Gross Margin (83.03%) than 88.89% of its industry peers.
In the last couple of years the Gross Margin of LLY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% |
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), LLY is creating value.
Compared to 1 year ago, LLY has about the same amount of shares outstanding.
Compared to 5 years ago, LLY has less shares outstanding
Compared to 1 year ago, LLY has a worse debt to assets ratio.
2.2 Solvency
LLY has an Altman-Z score of 8.14. This indicates that LLY is financially healthy and has little risk of bankruptcy at the moment.
LLY's Altman-Z score of 8.14 is amongst the best of the industry. LLY outperforms 94.44% of its industry peers.
LLY has a debt to FCF ratio of 6.60. This is a slightly negative value and a sign of low solvency as LLY would need 6.60 years to pay back of all of its debts.
LLY has a Debt to FCF ratio (6.60) which is comparable to the rest of the industry.
LLY has a Debt/Equity ratio of 1.72. This is a high value indicating a heavy dependency on external financing.
LLY has a Debt to Equity ratio of 1.72. This is in the lower half of the industry: LLY underperforms 75.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Altman-Z | 8.14 |
ROIC/WACC3.16
WACC9.12%
2.3 Liquidity
LLY has a Current Ratio of 1.55. This is a normal value and indicates that LLY is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.55, LLY is doing good in the industry, outperforming 62.96% of the companies in the same industry.
A Quick Ratio of 1.24 indicates that LLY should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.24, LLY is in the better half of the industry, outperforming 74.07% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 116.22% over the past year.
Measured over the past years, LLY shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.57% on average per year.
LLY shows a strong growth in Revenue. In the last year, the Revenue has grown by 45.41%.
The Revenue has been growing by 15.08% on average over the past years. This is quite good.
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%
3.2 Future
The Earnings Per Share is expected to grow by 31.53% on average over the next years. This is a very strong growth
Based on estimates for the next years, LLY will show a quite strong growth in Revenue. The Revenue will grow by 18.88% on average per year.
EPS Next Y84.93%
EPS Next 2Y58.19%
EPS Next 3Y45.43%
EPS Next 5Y31.53%
Revenue Next Year41.01%
Revenue Next 2Y29.88%
Revenue Next 3Y25.23%
Revenue Next 5Y18.88%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 46.16 indicates a quite expensive valuation of LLY.
Based on the Price/Earnings ratio, LLY is valued a bit more expensive than the industry average as 62.96% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 26.54. LLY is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 31.20, which means the current valuation is very expensive for LLY.
62.96% of the companies in the same industry are cheaper than LLY, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.78. LLY is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 46.16 | ||
| Fwd PE | 31.2 |
4.2 Price Multiples
70.37% of the companies in the same industry are cheaper than LLY, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LLY indicates a slightly more expensive valuation: LLY is more expensive than 68.52% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 149.07 | ||
| EV/EBITDA | 35.31 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of LLY may justify a higher PE ratio.
LLY's earnings are expected to grow with 45.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.54
PEG (5Y)2.79
EPS Next 2Y58.19%
EPS Next 3Y45.43%
5. Dividend
5.1 Amount
With a yearly dividend of 0.69%, LLY is not a good candidate for dividend investing.
LLY's Dividend Yield is comparable with the industry average which is at 2.05.
With a Dividend Yield of 0.69, LLY pays less dividend than the S&P500 average, which is at 1.96.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.69% |
5.2 History
On average, the dividend of LLY grows each year by 15.59%, which is quite nice.
Dividend Growth(5Y)15.59%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
LLY pays out 28.28% of its income as dividend. This is a sustainable payout ratio.
LLY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP28.28%
EPS Next 2Y58.19%
EPS Next 3Y45.43%
FRA:LLY (12/12/2025, 7:00:00 PM)
866.4
-6.3 (-0.72%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners83.08%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap819.08B
Revenue(TTM)59.42B
Net Income(TTM)18.41B
Analysts80.54
Price Target913.45 (5.43%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.69% |
Yearly Dividend4.21
Dividend Growth(5Y)15.59%
DP28.28%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.28%
Min EPS beat(2)14.51%
Max EPS beat(2)22.05%
EPS beat(4)4
Avg EPS beat(4)13.1%
Min EPS beat(4)6.45%
Max EPS beat(4)22.05%
EPS beat(8)7
Avg EPS beat(8)12.06%
EPS beat(12)10
Avg EPS beat(12)23.73%
EPS beat(16)13
Avg EPS beat(16)17.41%
Revenue beat(2)2
Avg Revenue beat(2)6.77%
Min Revenue beat(2)4.72%
Max Revenue beat(2)8.81%
Revenue beat(4)2
Avg Revenue beat(4)2.95%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)8.81%
Revenue beat(8)4
Avg Revenue beat(8)2.39%
Revenue beat(12)7
Avg Revenue beat(12)2.64%
Revenue beat(16)9
Avg Revenue beat(16)2.04%
PT rev (1m)14.68%
PT rev (3m)19.15%
EPS NQ rev (1m)1.23%
EPS NQ rev (3m)3.79%
EPS NY rev (1m)2.22%
EPS NY rev (3m)4.57%
Revenue NQ rev (1m)0.49%
Revenue NQ rev (3m)2.63%
Revenue NY rev (1m)1.69%
Revenue NY rev (3m)3.01%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 46.16 | ||
| Fwd PE | 31.2 | ||
| P/S | 16.15 | ||
| P/FCF | 149.07 | ||
| P/OCF | 59.73 | ||
| P/B | 40.33 | ||
| P/tB | 83.81 | ||
| EV/EBITDA | 35.31 |
EPS(TTM)18.77
EY2.17%
EPS(NY)27.77
Fwd EY3.21%
FCF(TTM)5.81
FCFY0.67%
OCF(TTM)14.5
OCFY1.67%
SpS53.66
BVpS21.49
TBVpS10.34
PEG (NY)0.54
PEG (5Y)2.79
Graham Number95.26
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROCE | 35.28% | ||
| ROIC | 28.84% | ||
| ROICexc | 33.25% | ||
| ROICexgc | 41.06% | ||
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% | ||
| FCFM | 10.83% |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
ROICexc(3y)23.23%
ROICexc(5y)21.74%
ROICexgc(3y)32.89%
ROICexgc(5y)32.31%
ROCE(3y)29.19%
ROCE(5y)26%
ROICexgc growth 3Y1.59%
ROICexgc growth 5Y4.02%
ROICexc growth 3Y9.55%
ROICexc growth 5Y8.82%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Debt/EBITDA | 1.44 | ||
| Cap/Depr | 507.66% | ||
| Cap/Sales | 16.2% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.78% | ||
| Profit Quality | 34.96% | ||
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 8.14 |
F-Score7
WACC9.12%
ROIC/WACC3.16
Cap/Depr(3y)385.26%
Cap/Depr(5y)286.02%
Cap/Sales(3y)16.93%
Cap/Sales(5y)13.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
EPS Next Y84.93%
EPS Next 2Y58.19%
EPS Next 3Y45.43%
EPS Next 5Y31.53%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%
Revenue Next Year41.01%
Revenue Next 2Y29.88%
Revenue Next 3Y25.23%
Revenue Next 5Y18.88%
EBIT growth 1Y82.81%
EBIT growth 3Y31.18%
EBIT growth 5Y24.1%
EBIT Next Year101.24%
EBIT Next 3Y46.41%
EBIT Next 5Y32.15%
FCF growth 1Y4003.21%
FCF growth 3Y-57.48%
FCF growth 5Y-34.68%
OCF growth 1Y158.46%
OCF growth 3Y6.69%
OCF growth 5Y12.76%
ELI LILLY & CO / LLY.DE FAQ
What is the fundamental rating for LLY stock?
ChartMill assigns a fundamental rating of 6 / 10 to LLY.DE.
What is the valuation status for LLY stock?
ChartMill assigns a valuation rating of 3 / 10 to ELI LILLY & CO (LLY.DE). This can be considered as Overvalued.
What is the profitability of LLY stock?
ELI LILLY & CO (LLY.DE) has a profitability rating of 9 / 10.
What is the financial health of ELI LILLY & CO (LLY.DE) stock?
The financial health rating of ELI LILLY & CO (LLY.DE) is 5 / 10.
What is the expected EPS growth for ELI LILLY & CO (LLY.DE) stock?
The Earnings per Share (EPS) of ELI LILLY & CO (LLY.DE) is expected to grow by 84.93% in the next year.